Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial

Chen, YL; Liu, XM; Li, QM; Ma, JH; Lv, XF; Guo, LX; Wang, CJ; Shi, YQ; Li, YB; Johnsson, E; Wang, M; Zhao, JN; Ji, LN

Ji, LN (reprint author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, 11 Xizhimen Nan Dajie, Beijing 100044, Peoples R China.

DIABETES OBESITY & METABOLISM, 2018; 20 (4): 1044

Abstract

This prospective, multicentre, phase III study (NCT02104804) evaluated the efficacy and safety of saxagliptin add-on therapy in Chinese patients with ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索